Find clinical trials for Alzheimer's Disease in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Berlin, BE, DEU:
Alzheimer's disease (AD) is the most common form of dementia. In the brains of people with AD, certain small substances stick toget ...
Phase 2
Berlin, Germany and 37 other locations
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...
Phase 2
Berlin, Germany and 71 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease...
Phase 3
Berlin, State of Berlin, Germany and 114 other locations
administered once every four weeks (Q4W) in slowing cognitive and functional decline as compared to placebo in participants with early Alzheimer's...
Phase 2
Berlin, Germany and 73 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determin...
Phase 3
Berlin, Germany and 246 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Steglitz, Germany and 142 other locations
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Berlin, Germany and 294 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Berlin, Germany and 149 other locations
The goal of this clinical trial is to evaluate the safety and efficacy of EXV-802 and EXV-801 in treatment of agitation in participants with Alzheimer's...
Phase 2, Phase 3
Berlin, State of Berlin, Germany and 48 other locations
This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...
Phase 3
Berlin, Germany and 200 other locations
Clinical trials
Research sites
Resources
Legal